It has recently been discovered that cell-cycle gene transcription is regulated by a core complex named LINC that switches from a transcriptionally repressive complex in G 0 -G 1 with the p130 or p107 pocket proteins and E2F4 to a transcriptionally active complex in S-G 2 containing B-Myb. We have studied the function of LINC in F9 embryonal carcinoma cells, which are distinguished by a rapid cell cycle resulting from an extremely short G 1 phase. We show that suppressing expression of the LINC component, Lin-9, in F9 cells causes arrest in mitosis, and we have used this system to screen for transcriptional targets. In these cells, B-Myb was found in complexes with Lin-9 and several other LINC constituents, however, the pocket proteins did not associate with LINC unless F9 cells were differentiated. Lin-9 and B-Myb were both required for transcription of G 2 /M genes such as Cyclin B1 and Survivin. Moreover, B-Myb was demonstrated to recruit Lin-9 to the Survivin promoter through multiple Myb-binding sites. The demonstration that a B-Myb/ LINC complex is vital for progression through mitosis in cells lacking a G 1 /S checkpoint has implications for both undifferentiated embryonal cells and for cancers in which pocket protein function is compromised.
Introduction
Cell-cycle gene transcription is regulated by core elements from the E2F transcription factor and the retinoblastoma pocket protein (pRb, p107 and p130) families. Typically, cell-cycle genes are repressed in G 0 /G 1 by E2F4/5-pocket protein complexes through recruitment of accessory factors such as histone deacetylases (HDACs), whereas activation at the G 1 /S transition results from replacement of the repressive complexes by activating E2F1/2/3A associated with histone acetyl transferases (Zhu et al., 2004; Cobrinik, 2005) . Displacement of repressive E2F complexes from the Cdc2 and Cyclin B1 gene promoters, which are maximally active during G 2 , also requires cooperation between activating E2Fs and the B-Myb transcription factor (Zhu et al., 2004) . In addition to their cell-cycle roles, E2F and Myb have recently been found to regulate gene expression during cell differentiation. This was strikingly demonstrated in Drosophila by characterization of the dREAM (Korenjak et al., 2004) or Myb-MuvB (Lewis et al., 2004) complexes that contain dE2F2 and dMyb (the orthologue of B-Myb) together with the Rb homologues RBF1 or RBF2, Caf1p55, three Myb-interacting proteins (Mip40, Mip120 and Mip130) and variously other components such as dLin-52. In addition to repressing genes transcribed in developmentally regulated and sex-specific patterns (Korenjak et al., 2004; Lewis et al., 2004) , it is now apparent that dREAM/Myb-MuvB also positively regulates G 2 /M genes (Georlette et al., 2007; Wen et al., 2008) .
Homologues of dREAM/Myb-MuvB have now been characterized in other invertebrates and vertebrates. Caenorhabditis elegans contains the DRM complex (Harrison et al., 2006) and three reports have identified human complexes, named LINC (or DREAM), whose composition is regulated at distinct phases of the cell cycle (Litovchick et al., 2007; Schmit et al., 2007; Pilkinton et al., 2007a) . LINC contains Lin-9, Lin-37, Lin-54, Lin-52 and RbAp48 (the human homologues of Drosophila Mip130, Mip40, Mip120, dLin-52 and Caf1p55, respectively). In G 0 -G 1 , LINC binds to E2F4 and either p130 or p107 to repress transcription of E2F target genes regulating the G 1 /S transition (Litovchick et al., 2007) . In S-G 2 , LINC switches to B-Myb to activate genes required for G 2 /M transition and mitosis (Schmit et al., 2007) . Depleting Lin-9 from human cells by RNA interference delayed the G 2 /M transition (Osterloh et al., 2006; Pilkinton et al., 2007b) and downregulated several genes required for entry into mitosis, spindle assembly and exit from mitosis (Osterloh et al., 2006) . Reporter assays have shown that Lin-9 and B-Myb coactivate transcription of G 2 /M genes and chromatin immunoprecipitations (ChIP) have located Lin-9 and B-Myb on their promoters (Osterloh et al., 2006; Schmit et al., 2007; Pilkinton et al., 2007b) .
In this study, we investigated the Lin-9/B-Myb interaction in F9 murine embryonal carcinoma (EC) cells, which in contrast to the cells previously studied are regulated only at the G 2 /M transition. In F9 cells, as in mouse embryonic stem (ES) cells (White et al., 2005) , the Rb, p107 and p130 pocket proteins are maintained in a hyperphosphorylated state. Consequently, there are no repressive E2F complexes and a lack of cell-cycle regulation at G 1 /S. We show that suppressing Lin-9 expression by RNA interference causes arrest in mitosis, and we used this system to screen for Lin-9 transcriptional targets. Subsequently, Lin-9 and B-Myb were shown to cooperate as transcriptional activators of key G 2 /M genes. Finally, we identified a B-Myb complex in F9 cells that contains most of the components identified previously in LINC. Significantly, no association between pocket proteins and LINC was detected in undifferentiated F9 cells, thereby demonstrating that the cell cycle is regulated by a B-Myb/LINC complex at the G 2 /M transition only.
Results
Depletion of Lin-9 in murine embryonal carcinoma cells reveals a mitotic defect Lin-9 was depleted from F9 cells by transfecting pSuper vectors encoding short hairpin RNAs (shRNAs) directed against murine Lin-9. Control cells were transfected with pSuper expressing a pGL3 luciferase shRNA. Quantitative PCR (qPCR) demonstrated that Lin-9 shRNA significantly decreased Lin-9 expression by 71% (Po0.02) compared with control cells (Figure 1a) . Western blot analysis confirmed that the Lin-9 protein was depleted specifically from cells transfected with Lin-9 shRNA (Figure 1b) . A rescue assay, in which human Lin-9 cDNA made resistant to RNA interference was cotransfected with pSuper/Lin-9, restored Lin-9 protein expression to control cell levels ( Figure 1b ). Flow cytometry (FACS) with propidium iodide (PI) staining showed that Lin-9 depletion caused a marked reduction of F9 cells with a 2n DNA content (G 1 ) and accumulation of cells with a 4n DNA content (G 2 /M) compared with control and rescue cells (Figure 1c) . Interestingly, cells with 8n DNA content were also observed on Lin-9 depletion. Decreased numbers of cells in G 1 and increased numbers of cells in G 2 /M were similarly observed in B-Myb-depleted F9 cells (Supplementary Figure S1a) , albeit the increase in G 2 /M cells was less pronounced and 8n cells were not apparent. The lesser effect of B-Myb depletion compared to Lin-9 may be explained by the extreme abundance of B-Myb in embryonal cells (Sitzmann et al., 1996) . Simultaneous depletion of Lin-9 and B-Myb had no additional effect compared to depletion of either of them alone (Supplementary Figure S1b ). We also found that expression of either B-Myb or Lin-9 shRNAs in pluripotent mouse ES cells resulted in an increased 4n cell population, and as for F9 cells the effect was more pronounced for Lin-9 (Supplementary Figure S1c) .
To determine if Lin-9-depleted cells accumulated in G 2 or mitosis, the cells were analysed by FACS and confocal microscopy. To determine the mitotic index, FACS was performed with cells stained with a histone H3 phosphoserine 10 (H3 phosphoS10) antibody, a marker for mitosis (Paulson and Taylor, 1982) . Cells depleted of Lin-9 showed an increased mitotic index (16.21%) compared with the control cells (3.59%) and rescue cells (3.10%; Figure 1d ). An additional population of cells with 8n DNA content was observed on Lin-9 depletion, and these cells stained positive for H3 phosphoS10 indicating they were in mitosis. Confocal microscopy of cells stained with b-tubulin antibody and DAPI showed a higher mitotic index (14.42%) in Lin-9-depleted cells compared with control (3.38%) and rescue cells (3.07%; Supplementary Figure S2 ). Cells depleted of Lin-9 contained single nuclei and formed a bipolar spindle during mitosis, indicating that accumulation of 4n and 8n cells was due to failure of mitosis rather than incorrect spindle formation or failure of cytokinesis.
Lin-9 is required for transcription of G 2 /M genes To identify Lin-9 target genes, microarray analysis was performed comparing RNA extracted from Lin-9-depleted and control F9 cells. Biotin-labelled cRNA was prepared and hybridized to the GeneChip mouse genome 430 2.0 array (Affymetrix, High Wycombe, UK). This analysis identified 331 known genes and a further 105 unannotated genes that showed consistent change in expression in three independent experiments. Of the known genes, 169 were downregulated and 162 were upregulated in Lin-9-depleted cells (Supplementary Table S1 ). Many of the downregulated cell-cycle genes are involved in mitosis (Figure 2a) , and this finding is consistent with the mitotic arrest observed in Lin-9-depleted F9 cells (Figure 1 ). These genes included Cyclin B1 and Cdc25B, which are required for G 2 /M progression, Plk1, Aurora kinase B and Survivin that are required for the spindle assembly checkpoint, Pttg1 and Ube2C that are required for exit from mitosis and FoxM1 that is a transcription factor functioning during mitosis (Figure 2a) . The remaining downregulated genes included those with diverse functions that include metabolism and development. Upregulated genes included those involved in signalling, differentiation and development or genes expressed during the G 1 phase, for example Cyclin E2 and PCNA. Upregulation of these genes possibly reflects their repression by a Lin-9 complex, however, it needs to be determined whether such complexes can be found at the promoters.
The downregulation of several G 2 /M genes in Lin-9-depleted cells was independently confirmed by qPCR (Figure 2b) . Significantly, the expression of genes regulated at the other cell-cycle stages was not diminished; Cyclin E2 that is required for G 1 /S transition was upregulated whereas B-Myb whose expression peaks during S-phase was unaffected (Figure 2b ). Interestingly, Cyclin A2 and Cdc2 expression was not significantly changed by depletion of Lin-9 in F9 cells, although previous studies in adult cells showed transcriptional dependence on Lin-9 (Osterloh et al., 2006) . B-Myb has been found to be required to remove a repressive E2F4 complex at the Cdc2 promoter (Zhu et al., 2004) , and possibly the lack of this repressor in F9 cells makes this activity redundant. In summary, our results indicate that Lin-9 is required for transcriptional activation of a specific set of key genes involved in the G 2 /M phase transition and during mitosis.
Lin-9 associates with B-Myb but not with the pocket proteins in F9 cells Previous studies have shown that Lin-9 forms complexes with either B-Myb or the p107/p130 pocket proteins at different stages of the cell cycle (Schmit et al., 2007; Pilkinton et al., 2007a) . Using immunoprecipitation and western blotting, it was evident that B-Myb was coprecipitated with Lin-9 from F9 cell extracts but p107 was not, despite its expression in these cells (Figure 3a) . Similar studies were also performed for p130; however, p130 was found not to be expressed under normal growth conditions in F9 cells (data not shown). In accord with previous studies, control experiments showed that B-Myb and p107 could both be coprecipitated with Lin-9 from mouse NIH3T3 cell extracts (Figure 3a) . Thus, in contrast to cells with an established G 1 /S cell-cycle checkpoint, Lin-9 does not form complexes with pocket proteins in undifferentiated F9 cells but is still able to interact with B-Myb.
The lack of a Lin-9/p107 interaction in F9 cells ( Figure 3a ) may result from the presence of constitutively active Cyclin A/E kinases that inactivate pocket protein functions. To test this notion, F9 cells were plated in conditions that induce endoderm differentiation; the differentiation marker Gata-4 was readily identified in these cells but not untreated F9 cells (Figure 3b ). Levels of B-Myb and p107 were decreased on differentiation, whereas, in contrast, expression of p130 was switched on (Figure 3c ). Significantly, F9 cell differentiation induced an interaction between Lin-9 and both p107 and p130; the residual B-Myb/ Lin-9 interaction detected may reflect incomplete differentiation ( Figure 3c ). It is clear that the pocket proteins can only complex with Lin-9 when F9 cells differentiate.
F9 cells contain a LINC-like complex that contains B-Myb and Lin-9
To test whether the other LINC constituents are required together with Lin-9 and B-Myb for mitosis in F9 cells, expression of Lin-54, Lin-37, Lin-52 or RbAp48 was depleted using specific shRNAs. qPCR was performed on RNA extracted from the shRNAtransfected cells and successful knockdown of Lin-54 (72%), Lin-37 (94%), Lin-52 (66%) and RbAp48 (94%) was confirmed (Po0.01; Figure 5a ). F9 cells depleted of Lin-54 had a comparable phenotype to cells depleted of Lin-9, in that 2n cell numbers were substantially decreased, whereas 4n cell numbers were increased along with the occurrence of cells with 8n DNA content ( Figure 5b ). Indeed, this phenotype was more pronounced than that obtained with Lin-9 shRNA ( Figure 1c ). No notable phenotypic difference was apparent on depletion of Lin-37 and Lin-52 compared to control cells, however, cells depleted of RbAp48 had a distinctive phenotype characterized by a large decrease in S phase cells and increased numbers of cells in G 1 (Figure 5b ).
To test whether the other LINC constituents are physically associated with B-Myb and Lin-9 in F9 cells, coimmunoprecipitation experiments were performed using antibodies directed to each of the LINC proteins. In undifferentiated F9 cells, Lin-9, Lin-54, Lin-37 and Lin-52 all interacted with B-Myb, whereas none interacted with p107 or p130. Intriguingly, one of the LINC components previously identified in adult cell lines, RbAp48, was not associated with B-Myb or Lin-9, Lin-54, Lin-37 and Lin-52 in F9 cells, despite being detected in the input samples ( Figure 4c ). As Lin-9 switches from B-Myb to pocket proteins in differentiated F9 cells (Figure 3c) , it was important to establish if other LINC components behaved similarly. On F9 cell differentiation, interactions between all the LINC proteins and B-Myb were greatly reduced, whereas p107 and p130 now formed complexes with Lin-9, Lin-54 and Lin-52 (Figure 4d ). To a much lesser extent, complexes between p107 and p130 with RbAp48 were also detected on differentiation, however, it is not clear that this occurred within LINC, as western blotting with an RbAp48 antibody did not detect this protein in Lin-9, Lin 54 or Lin52 immunoprecipitates (Figure 4d ). Unexpectedly, Lin-37 was not detected significantly in the p107 or p130 LINC complexes. These experiments demonstrated that B-Myb exists in a LINC complex in undifferentiated F9 cells and suggest that, like other cell types, the LINC components switch to p107 or p130 on cell-cycle exit. In contrast to studies on adult cells, we found no evidence that RbAp48 is a component of LINC in F9 cells.
As Lin-37 and Lin-52 appear to be integral components of the B-Myb/LINC complex in undifferentiated F9 cells, it was rather unexpected that shRNAs directed to these genes had no obvious cell-cycle effects (Figure 4b ). To ensure that these proteins were sufficiently depleted by RNA interference, LINC complexes were immunoprecipitated from F9 cells transfected with control, Lin-54, Lin-37, Lin 52 and Lin-37 shRNAs, and B-Myb was detected by western blotting. This experiment clearly demonstrated that the cognate shRNAs depleted Lin-54, Lin-37 and Lin-52 from complexes with B-Myb to a very significant extent, whereas complexes with RbAp48 were not detected as before (Figure 4e ). The results suggest that Lin-9, Lin-54 and B-Myb are critical for mitosis, whereas Lin-37 and Lin-52 are not essential for this function.
Lin-9 and B-Myb bind to and activate the promoters of G 2 /M genes To determine whether Lin-9 and B-Myb functionally interact in the transcriptional regulation of specific G 2 /M genes, binding of these proteins to the promoters of the Cyclin B1 and Survivin genes was assessed by ChIP. B-Myb and Lin-9 were both visualized on these promoters in this way (Figure 5a ), and qPCR was performed to quantify their enrichment as a percentage of the input chromatin (Figures 5b and 5c ). On both the Cyclin B1 and Survivin promoters, B-Myb and Lin-9 were significantly enriched (Po0.001). To provide evidence that Lin-9 and B-Myb exist in the same transcriptional complex on these promoters, the immunoprecipitated protein/chromatin complexes were reimmunoprecipitated using reciprocal antibodies (Figure 5d ). When either Lin-9 or B-Myb antibodies were used in the primary immunoprecipitation, the second reciprocal immunoprecipitation enriched for the Cyclin B1 and Survivin promoters, confirming that Lin-9 and B-Myb coexist on the same promoter templates (Figure 5d ).
To investigate whether Lin-9 and B-Myb cooperatively transactivate the Cyclin B1 and Survivin promoters, F9 cells were cotransfected with luciferase reporter plasmids containing either the Cyclin B1 or Survivin promoter and pSuper vectors encoding Lin-9 or B-Myb shRNAs. Depleting either Lin-9 or B-Myb from F9 cells significantly decreased the activity of the Cyclin B1 promoter when compared with control shRNA-transfected cells (Po0.02). Additionally, when both Lin-9 and B-Myb were depleted from the F9 cells the promoter activity was reduced further (Po0.001; Figure 5e ). A similar result was observed with the Survivin promoter, where depletion of both Lin-9 and B-Myb decreased the promoter activity approximately 10-fold (Po0.01; Figure 5f ). These results suggest that Lin-9 and B-Myb are both required for the activation of these promoters. MBS (mMBS-235, mMBS-677, mMBS-709 and mMBS-724) were identified in the Survivin promoter (Figure 6a ), and to determine their requirement for binding B-Myb and Lin-9, site-directed mutagenesis was carried out on each in turn (Supplementary Figure S3a) . Mutation of any one of the four MBS caused at least a 50% decrease in promoter activity compared with the wild-type (WT) promoter (Po0.001), with the mMBS-709 mutation having the least effect (Figure 6b) . Intriguingly, depleting both Lin-9 and B-Myb had no further significant effect on the promoter activity of any of the mutated promoters (Figure 6b ). To establish if the MBS act synergistically, Survivin promoter reporters were generated that contain mutations in all four MBS (mMBS-all) or the three MBS that cluster in the 5 0 region of the promoter (mMBS-5 0 cluster). Unexpectedly, mutating multiple MBS had no significant difference compared with mutating single MBS, suggesting that all four MBS are necessary for Survivin promoter activity (Figure 6c ).
To determine if B-Myb and/or Lin-9 binding to the Survivin promoter was MBS dependent, transient ChIP assays (Lavrrar and Farnham, 2004) were performed on F9 cells transfected with the WT and mutated reporters. To discriminate between the endogenous and reporter promoters, one of each pair of qPCR primers was designed to anneal to the pGL2-basic vector backbone or to the endogenous Survivin promoter only. Control experiments showed that B-Myb binding to the endogenous Survivin promoter was not significantly affected by the transient ChIP assay (Supplementary Figure  S3b) , although some noise (Btwofold) was seen with the rather lower Lin-9 binding, but this variation was considerably lower than that seen with the transfected promoters (Figure 6d ). The transfection efficiencies were comparable for each reporter (Supplementary Figure  S3c) . Levels of Lin-9 binding were significantly depleted by each MBS mutation when compared with the WT promoter (Po0.001), particularly for mMBS-235, mMBS-266 and mMBS-724 which showed no Lin-9 Figure 5 Lin-9 and B-Myb bind to and activate the Cyclin B1 and Survivin promoters. (a) Chromatin immunoprecipitations (ChIP) assays used chromatin extracted from F9 cells and antibodies directed to Histone H3K4(trimethyl) (H3K4), FAK (Irr Ab), Lin-9 and B-Myb. Binding to the Cyclin B1 and Survivin promoters was detected using specific PCR primers and agarose gel electrophoresis. In addition to focal adhesion kinase (FAK), further negative controls contained no antibody (No Ab) and a no-template PCR control (PCR -ve), whereas the positive control contained 1% of the chromatin input used in immunoprecipitations (IPs). (b and c) Results obtained in (a) were confirmed by quantitative PCR (qPCR) analysis for Cyclin B1 and Survivin using the Lin-9, B-Myb and FAK (Irr Ab) samples, and enrichment was estimated relative to the chromatin input. (d) Re-ChIP experiments with chromatin first immunoprecipitated with Lin-9 or B-Myb antibodies followed by a second IP with reciprocal antibodies. Bound DNA was quantified by qPCR and expressed relative to control re-ChIPs using FAK (Irr Ab) antibody. (e and f) Analysis of the activity of the (e) Cyclin B1 and (f) Survivin promoters using a luciferase assay on F9 cells transfected with shRNAs for Lin-9 and/or B-Myb. Control cells were transfected with shRNA GL3 (control).
binding to the promoter (Figure 6d ). Levels of B-Myb binding were also significantly decreased (Po0.001), ranging from a 2.3-fold (mMBS-709) to a 5.2-fold (mMBS-724) decrease. These findings therefore indicate that B-Myb recruits Lin-9 to the Survivin promoter through multiple MBS.
Discussion
In this study, depletion of Lin-9 in the F9 cell line, which has properties of pluripotent embryonal stem cells, was found to result in cell-cycle arrest or slowdown in mitosis with no evidence of increased cell death or differentiation. Several key mitosis control genes were shown to be downregulated in response to Lin-9 depletion, including Cyclin B1, Plk1, Aurora kinases A and B, FoxM1 and Survivin, therefore, it is likely that reduction in expression of these genes directly contributed to the observed phenotype. Evidence that Lin-9 activates transcription of G 2 /M genes in F9 cells in a complex with B-Myb was suggested by several observations. First, treatment of F9 cells with B-Myb shRNAs gave a similar mitotic arrest phenotype (Supplementary Figure S1) , albeit arrest was less pronounced than with Lin-9 shRNA as B-Myb is extremely abundant in embryonal stem cells (Sitzmann et al., 1996) and may be more difficult to deplete. Second, Lin-9 was shown to form complexes only with B-Myb and not with p130 or p107 in undifferentiated F9 cells (Figure 3a) . Third, genes such as Cyclin B1 whose expression is dependent on Lin-9 in F9 cells (Figure 1b) are known transcriptional target of B-Myb (Zhu et al., 2004) . Fourth, both Lin-9 and B-Myb were found to be required for transcription from transfected Cyclin B1 and Survivin promoters (Figures 5e and f) . Finally, ChIP analyses showed that Lin-9 was found together with B-Myb on the Cyclin B1 and Survivin promoters (Figures 5a-c) and further experiments demonstrated that Lin-9 was recruited to the Survivin promoter through MBS (Figure 6 ).
EC cells, such as mouse ES cells, have a rapid cell cycle with a severely truncated G 1 phase. These cells lack repressive E2F complexes, most likely because they contain highly active Cdk2 associated with Cyclin E/A, which precludes pocket protein/E2F4 interactions. Our finding that Lin-9 and B-Myb are required for transcription of G 2 /M genes in F9 cells, therefore, strongly supports the notion that a B-Myb/LINC complex acts directly in transcriptional activation. Significantly, this system permits analysis of LINC function in gene activation without the confounding background of gene repression mediated by LINC complexes with E2F4 and the pocket proteins p130 and p107 (the dREAM complex). Some previous results suggest that LINC proteins were enriched only on genes upregulated at G 1 /S through interaction with p130/ E2F4 and p107/E2F complexes (Litovchick et al., 2007) , and that the primary function of these complexes is to repress transcription of cell-cycle genes in G 0 /G 1 . It was also suggested that B-Myb activated Cdc2 and Cyclin B1 transcription during G 2 through replacement of repressive E2F complexes with activating E2Fs (Zhu et al., 2004 ). Our results demonstrate that B-Myb/LINC functions in the complete absence of repressive pocket protein/E2F4 complexes, indicating that its role is implicitly required for G 2 /M gene transcription and not simply to supplant repressive complexes.
We found that other LINC components in addition to Lin-9 are strongly associated with B-Myb in F9 cells (Figure 4c ), indicating that the F9 cell LINC complex is related to that in adult cells (Schmit et al., 2007) . Although the F9 cell B-Myb/LINC complex similarly contains Lin-9, Lin-54, Lin-37, Lin-52, there is the notable absence of RbAp48. RbAp48, a histone-binding protein, is found in several Rb-associated complexes such as NuRD and Sin3, which are associated with transcription repression by HDAC (Loyola and Almouzni, 2004) . In Drosophila, Caf1p55 (the RbAp48 homologue) is required for repression of E2F-regulated genes, but not for activation . Thus it is possible that RbAp48 function is not required for embryonal cell B-Myb/LINC function, as this complex has exclusively transcription activation properties. It is of interest that depleting RbAp48 from F9 cells resulted in G 1 arrest rather than a mitotic block (Figure 4b ), suggesting that RbAp48 is a component of other complexes that moderate cell-cycle arrest at G 1 /S or alternatively prevent the onset of differentiation. Suppressing Lin-54 expression had a similar mitotic block phenotype to that of Lin-9 depletion, whereas Lin-37 and Lin-52 depletion had no obvious effect on the cell cycle (Figure 4b) . Schmit et al. (2007) found that suppressing Lin-37 had little effect on the expression of G 2 /M genes in adult cells; however, Lin-52 depletion did reduce expression of several G 2 /M genes. It is not clear why Lin-52 depletion in F9 cells had no phenotype, as RNA interference clearly reduced protein levels very significantly (Figure 4e ). Studies in Drosophila cells showed many different subsets of genes with different requirements for non-core dREAM/Myb-MuvB components, including Lin-52 (Georlette et al., 2007) . Conceivably, Lin-52 function is not critically required for the mitotic functions activated by B-Myb/LINC, although it may contribute to the transcription of genes with other functions.
ChIP analyses showed that Lin-9 and B-Myb bound to the Cyclin B1 and Survivin promoters, and both were required for transcription in F9 cells ( Figure 5 ). LINC is presumably recruited to promoters through its binding partners, B-Myb in F9 cells and E2F4 in other instances, as apart from Lin-54 no other LINC components is known to be a DNA-binding protein. To test this, we mutated the four potential MBS in the murine Survivin promoter and found unexpectedly that mutation of any site decreased promoter activity; moreover, the mutant promoters were all deficient in binding both B-Myb and Lin-9 in transient ChIP assays (Figure 6 ). Mutating all four MBS in the Survivin promoter did not further decrease promoter activity or Lin-9 and B-Myb binding, suggesting that the individual MBS act cooperatively to attain a critical threshold for B-Myb binding. Although in some instances individual MBS in G 2 /M gene promoters are conserved across species, as is the case for Cyclin B1 (Zhu et al., 2004) , more often these sites are not conserved. Rather, as in the Survivin promoter, the exact locations of MBS within the promoter may not be essential, but more importantly a cluster of sites may be needed to nucleate B-Myb/LINC binding. Of relevance to this argument is our previous finding that in vitro binding of full-length B-Myb could be demonstrated with a DNA sequence containing three MBS, but not to a single MBS (Bessa et al., 2001) . It can be concluded that B-Myb DNA-binding activity is required to recruit Lin-9 and by extension LINC to the Survivin promoter. Studies in Drosophila have shown that the lethal Myb-null phenotype can be rescued by a Myb mutant lacking its DNA-binding domain (Wen et al., 2008) , and it was suggested that one possible explanation for this phenomenon is that the mutant protein could still be recruited via dREAM/Myb-MuvB complexes to activate transcription. Our findings suggest that, in contrast, B-Myb DNA-binding specificity is needed for activation of at least some G 2 /M promoters in mammalian cells.
B-Myb-null mutant mice die at E4.5-6.5 due to failure of the inner cell mass to grow (Tanaka et al., 1999) . Although the precise cause of this lethality is not known, evidence is emerging that B-Myb depletion in mouse ES cells (the in vitro counterpart of the inner cell mass) results in mitotic failure (Tarasov et al., 2008) . Moreover, B-Myb appears to play a part in maintaining expression of genes such as Sox2 and Oct4 required for pluripotency in ES cells, and when B-Myb is depleted the result is increased differentiation and apoptosis (Tarasov et al., 2008) . Although our findings indicate that B-Myb is required for transcription of G 2 /M genes in embryonal cells through complex formation with LINC, a recent report suggests that B-Myb is also involved in a novel complex containing clathrin and filamin that is required for localization of clathrin on the mitotic spindle and stabilization of the kinetochores (Yamauchi et al., 2008) . Thus B-Myb may be involved at more than one level in mitosis as well as in maintenance of stem-cell pluripotency, and it will be of interest to discover which of these functions explains the early lethality of the B-Myb-null embryo.
Elevated expression levels of B-Myb and G 2 /M genes such as Cyclin B1 and Survivin correlate with poor prognosis in a range of human cancers and often lead to evasion of chemotherapies such as tamoxifen for breast cancer (Paik et al., 2004; Rhodes et al., 2004) . It is now axiomatic that E2F-mediated repression of cell-cycle gene transcription is defective in cancers through inactivation of pocket proteins, most often through failure to regulate Cdk activity. In respect of pocket protein inactivity, there are similarities between cancers and embryonal stem cells. Our finding that transcription of a set of G 2 /M genes in undifferentiated embryonal cells is dependent on B-Myb/LINC suggests that overexpression of these genes in cancers could potentially be targeted by preventing the formation of this complex.
Materials and methods
Cell culture and shRNA transfections F9 murine EC cells were incubated at 37 1C and 10% CO 2 in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 2 mM L-glutamine and 50 U/ml penicillin/ streptomycin. Sense and antisense shRNA oligonucleotides were annealed and ligated into pSuper (a gift from Dr R Beijersbergen, NKI, Amsterdam, Netherlands). Sequences are available in the Supplementary information. 5 Â 10 5 F9 cells were seeded and transfected with 2 mg pSuper and 1 mg PGKpuro using 15 ml lipofectamine 2000 and OptiMEM (Invitrogen, Paisley, UK), selected with 5 mg/ml puromycin and harvested 96 hours after transfection. Rescue assays were established by cotransfecting cells with 3 mg pCAGGS-Lin-9, where the Lin-9 transcript was rendered resistant to shRNA by synonymous codon mutations. F9 cells were differentiated for 7 days by adding 1 mM retinoic acid, 1 mM dibutyryl-adenosine-3 0 -5 0 -monophosphate and 0.1 mM isobutyl methyl xanthine to the medium.
RNA extraction, cDNA microarrays and qPCR Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Crawley, UK) and reverse transcribed using Reverse-iT RTase (ABgene, Epsom, UK). qPCR was performed using Absolute SYBR green ROX (ABgene) and an ABI Prism 7700 sequence detector. Relative quantification was calculated by normalizing against ARP P0 gene primers. Primer sequences are available on request. Each PCR reaction was carried out on biological triplicates. Biotin-labelled cRNA was prepared from total RNA and hybridized to a GeneChip Mouse Genome 430 2.0 Array (Affymetrix). The GeneChips were analysed by the microarray facility at The Wolfson Institute for Biomedical Research (UCL, London, UK) using the analysis of variance (ANOVA) and significance analysis of microarrays (SAM) statistical methods. Each hybridization was carried out on biological triplicates.
Immunoprecipitations and western blotting
Whole cell lysates were prepared in freeze/thaw buffer (250 mM NaCl, 20 mM HEPES pH 7.4, 5 mM MgCl 2 , 0.5 mM EDTA, 5 mM NaF, 0.1% NP40, 10% glycerol, 1 mM DTT) containing Complete protease inhibitor cocktail (Roche, Mannheim, Germany), freeze-thawed twice and clarified by ultracentrifugation at 100 000 g. Nuclear lysates were prepared by passing cells through a 25G syringe needle in buffer A (10 mM HEPES pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 1 mM NaF, 1 mM DTT and Complete protease inhibitors; Roche), collecting nuclei by brief microcentrifugation followed by incubation in one volume buffer B (20 mM HEPES pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 450 mM NaCl, 1 mM NaF, 25% glycerol, 1 mM DTT and Complete protease inhibitors; Roche). After microcentrifugation at 14 000 r.p.m. for 10 min, 300 mg of the cleared nuclear lysate was diluted with an equal volume of 20 mM HEPES, pH 7.9 and mixed with 2 mg of antibody overnight at 4 1C. Protein G Sepharose beads were added and incubated for one hour at 4 1C to collect immune complexes, washed four times with IP buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 10% glycerol, 0.5% Triton-X100) and eluted in SDSpolyacrylamide gel electrophoresis (PAGE) sample buffer. Proteins were resolved by SDS-PAGE, transferred to nitrocellulose membrane and western blotted using standard techniques.
Flow Cytometry FACS was performed on ethanol fixed cells stained with PI using a FACSort analyser and analysed with CELLQuest (Becton Dickinson, San Jose, CA, USA) and FlowJo (Tree Star Inc., Ashland, OR, USA) software. For dual staining, cells were incubated in 0.75 mg rabbit anti-histone H3(phosphoS10) antibody (ab5176; Abcam, Cambridge, UK) in 1% bovine serum albumin (BSA)/phosphate-buffered saline (PBS), washed, incubated in sheep anti-rabbit-FITC antibody in 1% BSA/PBS and counterstained with PI. At least 15 000 cells were counted.
Antibodies
The Lin-9 polyclonal antibody (raised in rabbits against human Lin-9 amino acids 227-559) was purified using a protein A Sepharose column. The B-Myb LX015.1 monoclonal antibody was described previously (Tavner et al., 2007) . Histone H3K4(trimethyl) (ab8580), polyclonal RbAp48 (ab50307) and monoclonal RbAp48 (ab488) antibodies were from Abcam; focal adhesion kinase (FAK) (sc-903), B-Myb (sc-724), p107 (sc-318), p130 (sc-317) and Cyclin B1 (sc-245) antibodies were from Santa Cruz (Santa Cruz, CA, USA); b-actin (A-2066) and b-tubulin (C-4585) antibodies were from Sigma (Poole, UK). Polyclonal antibodies for Lin-37, Lin-54 and Lin-52 were a kind gift from Stephan Gaubatz (University of Wu¨rzburg, Wu¨rzburg, Germany).
Luciferase reporter assays
Approximately 1 kb upstream of the transcription start sites of mouse Cyclin B1 and Survivin was PCR amplified and cloned into pGL2-basic (Promega, Madison, WI, USA) using KpnI and NheI sites in the primer sequences (Cyclin B1: GCGGTACCATGTTTCTTCGGGACGTGAC and GCGC TAGCCTCCGCCAAGACGACTCAA; Survivin: GCGGTA CCATGTTTCTTCGGGACGTGAC and GCGCTAGCCTC CGCCAAGACGACTCAA). For luciferase assays, 10 5 F9 cells plated in 24-well dishes were transfected with 0.33 mg of pGL2-basic luciferase reporter, 0.4 mg of pSuper shRNA and 0.1 mg of pSV-bgal transfection control using 2 ml lipofectamine 2000 and OptiMEM. After incubating for 24-48 hours, the luciferase activity was measured as described previously (Tavner et al., 2007) .
Chromatin immunoprecipitation F9 cells were subjected to ChIP as described previously (Tavner et al., 2007) . Cross-linked chromatin (25 mg) was immunoprecipitated with Lin-9 and B-Myb polyclonal antibodies, and control antibodies against Histone H3K4(trimethyl) and FAK. A further control contained chromatin but no antibody. Following DNA elution, qPCR was performed using primers for Cyclin B1 (GAAACGCATTCTACG GGAAC and TCACCCTAGTGACCCTGAGC) and Survivin (CTGCGGAAGATTCGAGTCAG and ATGATGGCG TCACCACAAC). Specific enrichment was calculated relative to input chromatin levels using % of input ¼ 2 DCt , where DCt ¼ Ct 1% input -Ct IP . Re-ChIP experiments were performed as described by Osterloh et al. (2006) . Each ChIP experiment was carried out on biological triplicates.
The pGL2-Survivin reporter plasmid was mutated using PCR with primers (mMBS-235: GAGTCAGAATAGCAAGA AGGAATTCCAGCAGAAGGTACAACT; mMBS-677: GG CTCAGCAGCCTGCAGTCACACCC; mMBS-709: AGAC ACTGAACCCGGGCCCGCAGCAA; mMBS-724: GCCG CCCGACAGGAATTCAGACACTGAAAAC). Transient ChIP assays for transfected WT and mutant Survivin promoters were analysed by qPCR (Lavrrar and Farnham, 2004 ) using a forward primer annealing to the pGL2-basic vector (AGCTAACATAACCCGGGAGGTA) and a reverse primer annealing to the Survivin promoter (GCCCTGATA ATTCGGTTTCCTTTTC). Primers amplifying the endogenous Survivin promoter controlled for variations in promoter amplification and a b-gal assay confirmed comparable transfection efficiencies. Enrichment of the promoter was calculated relative to the irrelevant antibody control. Each assay was performed on biological triplicates.
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